LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Jan. 9, 2006--BioSante Pharmaceuticals, Inc. (AMEX:BPA) today announced that BioSante has engaged Eugene V. DeFelice as an independent consultant to assist BioSante with corporate and business development activities, including licensing, mergers and acquisitions, as well as intellectual property management, regulatory affairs, and compliance.
